{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:25:34Z","timestamp":1793805934294,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urolonc.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:34:38Z","timestamp":1783632878000},"page":"434-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal utDNA dynamics predict recurrence risk in upper tract urothelial carcinoma: A prospective cohort study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-7186","authenticated-orcid":false,"given":"Wei","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanqing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2026.06.011_bib0001","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.011_bib0002","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/JU.0000000000001786","article-title":"Risk factors for intravesical recurrence after minimally invasive nephroureterectomy for upper tract urothelial cancer (ROBUUST Collaboration)","volume":"206","author":"Katims","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.011_bib0003","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.011_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrurol.2013.299","article-title":"Bladder cancer: tumour recurrence after radical nephroureterectomy for UTUC","volume":"11","author":"Ouzzane","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.011_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/21681805.2015.1026937","article-title":"Bladder cancer detection in patients with gross haematuria: computed tomography urography with enhancement-triggered scan versus flexible cystoscopy","volume":"49","author":"Helenius","year":"2015","journal-title":"Scand J Urol"},{"issue":"18","key":"10.1016\/j.urolonc.2026.06.011_bib0006","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2024.02.001","article-title":"Blood-based liquid biopsy: a promising noninvasive test in diagnosis, surveillance, and prognosis of patients with upper tract urothelial carcinoma","volume":"42","author":"Ghoreifi","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.06.011_bib0008","unstructured":"Chou R, Buckley D, Fu R, Gore JL, Gustafson K, Griffin J, et al. AHRQ comparative effectiveness reviews. In: Emerging approaches to diagnosis and treatment of non\u2013muscle-invasive bladder cancer. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015."},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.011_bib0009","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/JU.0000000000003188","article-title":"A urine-based DNA methylation marker test to detect upper tract urothelial carcinoma: a prospective cohort study","volume":"209","author":"Ghoreifi","year":"2023","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.011_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-023-01729-7","article-title":"Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma","volume":"22","author":"Yang","year":"2023","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.011_bib0011","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/JU.0000000000001878","article-title":"Urinary molecular pathology for patients with newly diagnosed urothelial bladder cancer","volume":"206","author":"Zhang","year":"2021","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2026.06.011_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41585-023-00725-2","article-title":"Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease","volume":"20","author":"Rose","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.011_bib0013","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"issue":"21","key":"10.1016\/j.urolonc.2026.06.011_bib0014","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1158\/1078-0432.CCR-20-0401","article-title":"Noninvasive detection of urothelial carcinoma by cost-effective low-coverage whole-genome sequencing from urine-exfoliated cell DNA","volume":"26","author":"Zeng","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.urolonc.2026.06.011_bib0015","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.011_bib0016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder EpiCheck\u2122 methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"20","key":"10.1016\/j.urolonc.2026.06.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70346","article-title":"A novel urine DNA predictor for noninvasive early diagnosis and monitoring minimal residual disease of upper tract urothelial carcinoma","volume":"13","author":"Zuo","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.urolonc.2026.06.011_bib0018","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1097\/JS9.0000000000001372","article-title":"Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis","volume":"110","author":"Liu","year":"2024","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.011_bib0019","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.euo.2023.08.009","article-title":"Early on-treatment circulating tumor DNA measurements and response to immune checkpoint inhibitors in advanced urothelial cancer","volume":"7","author":"Tolmeijer","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.011_bib0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41416-021-01648-8","article-title":"Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma","volume":"126","author":"Shohdy","year":"2022","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2026.06.011_bib0021","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1078-0432.CCR-22-3250","article-title":"Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle-invasive bladder cancer","volume":"29","author":"Christensen","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.011_bib0022","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.annonc.2023.12.007","article-title":"Liquid biopsy response evaluation criteria in solid tumors (LB-RECIST)","volume":"35","author":"Gouda","year":"2024","journal-title":"Ann Oncol"},{"issue":"7867","key":"10.1016\/j.urolonc.2026.06.011_bib0023","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.011_bib0024","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jmoldx.2024.01.006","article-title":"The clinical validity of urinary pellet DNA monitoring for the diagnosis of recurrent bladder cancer","volume":"26","author":"Abe","year":"2024","journal-title":"J Mol Diagn"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:27:43Z","timestamp":1793802463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1078143926005697"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal utDNA dynamics predict recurrence risk in upper tract urothelial carcinoma: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}